Nicotinic acid hydroxamate downregulated the melanin synthesis and tyrosinase activity through activating the MEK/ERK and AKT/GSK3β signaling pathways.

In this study, nicotinic acid hydroxamate (NAH), a nicotinic acid derivative, was found to show dose-dependent inhibition of melanin content and tyrosinase activity of murine melanoma B16F10 cells with or without being cotreated with cAMP stimulators. In the studies on signaling pathways for skin whitening, NAH-treated B16F10 cells resulted in a decrease in the expression of tyrosinase, tyrosinase-related protein-1, and microphthalmia-associated transcription factor (MITF). PD98059 and LY294002 additions were obviously to increase melanin contents in B16F10 cells; however, they were reversed by NAH cotreatments. NAH-mediated increases in the phosphorylation of mitogen-activated protein kinase kinase (MEK)/ERK and AKT/glycogen synthase kinase-3β (GSK3β) were also found, which in turn led to the inhibition of MITF expression and then downregulated tyrosinase and tyrosinase-related protein (TRP)-1 expressions. These results suggest that NAH may be an active component in the inhibition of melanogenesis, which will have potential uses as cosmetics for whitening and need further investigation.

[1]  Shyr‐Yi Lin,et al.  Effects of nicotinic acid derivatives on tyrosinase inhibitory and antioxidant activities , 2012 .

[2]  Duck-Hee Kim,et al.  Hydroxamic Acid Derivatives as Antimelanogenic Agents: The Importance of a Basic Skeleton and Hydroxamic Acid Moiety. , 2009 .

[3]  Duck-Hee Kim,et al.  Hydroxamic Acid Derivatives as Anti-melanogenic Agents: The Importance of a Basic Skeleton and Hydroxamic Acid Moiety , 2009 .

[4]  Sun Hee Jin,et al.  Methyl-β-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK , 2008, Archives of Dermatological Research.

[5]  H. Kwon,et al.  Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model. , 2008, The Journal of investigative dermatology.

[6]  I. S. Dunn,et al.  Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression , 2006, Molecular Cancer Research.

[7]  N. Copeland,et al.  Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.

[8]  R. Boissy.  Melanosome transfer to and translocation in the keratinocyte , 2003, Experimental dermatology.

[9]  Kyoung-Chan Park,et al.  Sphingosine-1-phosphate-induced ERK activation protects human melanocytes from UVB-induced apoptosis , 2003, Archives of pharmacal research.

[10]  G. Scott,et al.  The cAMP signaling pathway has opposing effects on Rac and Rho in B16F10 cells: implications for dendrite formation in melanocytic cells. , 2003, Pigment cell research.

[11]  M. Khaled,et al.  Glycogen Synthase Kinase 3β Is Activated by cAMP and Plays an Active Role in the Regulation of Melanogenesis* , 2002, The Journal of Biological Chemistry.

[12]  C. Walker,et al.  Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. , 2001, Chemical research in toxicology.

[13]  H. Nagai,et al.  Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. , 2000, The Journal of investigative dermatology.

[14]  M. Page,et al.  Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. , 2000, Journal of medicinal chemistry.

[15]  R. Buscà,et al.  Cyclic AMP a key messenger in the regulation of skin pigmentation. , 2000, Pigment cell research.

[16]  E. Price,et al.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. , 2000, Genes & development.

[17]  D. Chakrabarti,et al.  Antimalarial Activities of Polyhydroxyphenyl and Hydroxamic Acid Derivatives , 1998, Antimicrobial Agents and Chemotherapy.

[18]  A. Brunet,et al.  Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation* , 1998, The Journal of Biological Chemistry.

[19]  T. Kouzarides,et al.  CBP/p300 as a co-factor for the Microphthalmia transcription factor , 1997, Oncogene.

[20]  K Takahashi,et al.  Functional Analysis of Microphthalmia-associated Transcription Factor in Pigment Cell-specific Transcription of the Human Tyrosinase Family Genes* , 1997, The Journal of Biological Chemistry.

[21]  R. Buscà,et al.  Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation* , 1996, The Journal of Biological Chemistry.

[22]  M. Eller,et al.  Mechanisms of Ultraviolet Light‐Induced Pigmentation , 1996, Photochemistry and photobiology.

[23]  A. Thody,et al.  Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. , 1994, Journal of cell science.

[24]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  K. Sugihara,et al.  Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides. , 1986, Archives of biochemistry and biophysics.

[26]  K. Harada,et al.  Comparative studies of nicotinohydroxamic acid and neomycin on ammonia and urea metabolism in rats. , 1985, Research communications in chemical pathology and pharmacology.

[27]  S. Pomerantz,et al.  Regulation of tyrosinase in human melanocytes grown in culture , 1983, The Journal of cell biology.

[28]  Y. Shimada,et al.  A controlled clinical trial of nicotinohydroxamic acid and neomycin in advanced chronic liver disease. , 1982, Digestion.

[29]  J. Daly,et al.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Blum,et al.  Studies on the mechanism of inhibition of redox enzymes by substituted hydroxamic acids. , 1978, Biochimica et biophysica acta.

[31]  K. Kobashi,et al.  Effect of acyl residues of hydroxamic acids on urease inhibition. , 1971, Biochimica et biophysica acta.